123 related articles for article (PubMed ID: 18569844)
1. Chemical and functional analysis of generic hydroxyurea formulations.
Harrod VL; Howard T; Abboud MR; Hankins J; Lobo C; Ware RE
Pediatr Hematol Oncol; 2008 Jun; 25(5):423-9. PubMed ID: 18569844
[TBL] [Abstract][Full Text] [Related]
2. Hydroxyurea for children with sickle cell disease.
Heeney MM; Ware RE
Pediatr Clin North Am; 2008 Apr; 55(2):483-501, x. PubMed ID: 18381097
[TBL] [Abstract][Full Text] [Related]
3. Hydroxyurea therapy associated with declining serum levels of magnesium in children with sickle cell anemia.
Altura RA; Wang WC; Wynn L; Altura BM; Altura BT
J Pediatr; 2002 May; 140(5):565-9. PubMed ID: 12032523
[TBL] [Abstract][Full Text] [Related]
4. Plasma and urine hydroxyurea levels might be useful in the management of adult sickle cell disease.
Bachir D; Hulin A; Huet E; Habibi A; Nzouakou R; El Mahrab M; Astier A; Galacteros F
Hemoglobin; 2007; 31(4):417-25. PubMed ID: 17994375
[TBL] [Abstract][Full Text] [Related]
5. Hydroxyurea treatment in children with sickle cell anemia in Central America and the Caribbean countries.
Svarch E; Machín S; Nieves RM; Mancia de Reyes AG; Navarrete M; Rodríguez H
Pediatr Blood Cancer; 2006 Jul; 47(1):111-2. PubMed ID: 16550531
[No Abstract] [Full Text] [Related]
6. The measurement of urinary hydroxyurea in sickle cell anaemia.
Dalton RN; Turner C; Dick M; Height SE; Awogbade M; Inusa B; Okpala I; O'Driscoll S; Thein SL; Rees DC
Br J Haematol; 2005 Jul; 130(1):138-44. PubMed ID: 15982356
[TBL] [Abstract][Full Text] [Related]
7. Hydroxyurea therapy: improving the lives of patients with sickle cell disease.
Anderson N
Pediatr Nurs; 2006; 32(6):541-3. PubMed ID: 17256291
[TBL] [Abstract][Full Text] [Related]
8. Effect of hydroxyurea on the deformability of the red blood cell membrane in patients with sickle cell anemia.
Athanassiou G; Moutzouri A; Kourakli A; Zoumbos N
Clin Hemorheol Microcirc; 2006; 35(1-2):291-5. PubMed ID: 16899945
[TBL] [Abstract][Full Text] [Related]
9. When should hydroxyurea be used for children with sickle cell disease?
Mueller BU
Pediatrics; 2008 Dec; 122(6):1365-6. PubMed ID: 19047256
[No Abstract] [Full Text] [Related]
10. Pharmacokinetics of hydroxyurea 1,000 mg coated breakable tablets and 500 mg capsules in pediatric and adult patients with sickle cell disease.
de Montalembert M; Bachir D; Hulin A; Gimeno L; Mogenet A; Bresson JL; Macquin-Mavier I; Roudot-Thoraval F; Astier A; Galactéros F
Haematologica; 2006 Dec; 91(12):1685-8. PubMed ID: 17145606
[TBL] [Abstract][Full Text] [Related]
11. Hydroxyurea and new agents for the treatment of sickle cell disease.
Rodgers GP
Clin Adv Hematol Oncol; 2004 Nov; 2(11):713-5. PubMed ID: 16163257
[No Abstract] [Full Text] [Related]
12. [Effect of hydroxyurea on adhesion proteins in sickle cell anemia].
Odièvre MH; Lapouméroulie C; Elion J
Arch Pediatr; 2009 Feb; 16(2):95-8. PubMed ID: 19167870
[No Abstract] [Full Text] [Related]
13. Hydroxyurea for sickle cell anemia.
Bachmeyer C; Aractingi S; Lionnet F
N Engl J Med; 2008 Jul; 359(1):98; author reply 98-9. PubMed ID: 18609755
[No Abstract] [Full Text] [Related]
14. Are we underestimating the leukemogenic risk of hydroxyurea.
Al-Jam'a AH; Al-Dabbous IA; Al-Khatti AA; Esan FG
Saudi Med J; 2002 Nov; 23(11):1411-3. PubMed ID: 12506308
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic and genotoxic monitoring of sickle cell anaemia patients treated with hydroxyurea.
Khayat AS; Antunes LM; Guimarães AC; Bahia MO; Lemos JA; Cabral IR; Lima PD; Amorim MI; Cardoso PC; Smith MA; Santos RA; Burbano RR
Clin Exp Med; 2006 Mar; 6(1):33-7. PubMed ID: 16550342
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow transplantation or hydroxyurea for sickle cell anemia: long-term effects on semen variables and hormone profiles.
Lukusa AK; Vermylen C; Vanabelle B; Curaba M; Brichard B; Chantrain C; Dupont S; Ferrant A; Wyns C
Pediatr Hematol Oncol; 2009 Jun; 26(4):186-94. PubMed ID: 19437321
[TBL] [Abstract][Full Text] [Related]
17. [Hydroxyurea treatment in patients affected with sickle cell anemia: efficacy and safety].
de Montalembert M
Transfus Clin Biol; 2008; 15(1-2):34-8. PubMed ID: 18499496
[TBL] [Abstract][Full Text] [Related]
18. Hydroxyurea in sickle cell disease--a study of clinico-pharmacological efficacy in the Indian haplotype.
Italia K; Jain D; Gattani S; Jijina F; Nadkarni A; Sawant P; Nair S; Mohanty D; Ghosh K; Colah R
Blood Cells Mol Dis; 2009; 42(1):25-31. PubMed ID: 18954999
[TBL] [Abstract][Full Text] [Related]
19. Managing acute chest syndrome of sickle cell disease in an African setting.
Fawibe AE
Trans R Soc Trop Med Hyg; 2008 Jun; 102(6):526-31. PubMed ID: 18455745
[TBL] [Abstract][Full Text] [Related]
20. Comparison of simvastatin tablets from the US and international markets obtained via the Internet.
Veronin MA; Nguyen NT
Ann Pharmacother; 2008 May; 42(5):613-20. PubMed ID: 18413690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]